Pfizer Inc.
STABLE AQUEOUS ANTIBODY FORMULATION

Last updated:

Abstract:

The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.

Status:
Application
Type:

Utility

Filling date:

6 Jan 2021

Issue date:

6 May 2021